GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRsGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRsGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs

GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs

No trades
See on Supercharts
Market capitalization
‪88.17 B‬USD
0.49USD
‪2.92 B‬USD
‪35.61 B‬USD
Beta (1Y)
−0.15

About GSK plc


CEO
Emma N. Walmsley
Website
Headquarters
London
ISIN
ARDEUT110483
FIGI
BBG003641Z45
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Check out other big names from the same industry as GSKC.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Displays a symbol's price movements over previous years to identify recurring trends.
XS86659697
GlaxoSmithKline Capital Plc 4.25% 18-DEC-2045
Yield to maturity
5.72%
Maturity date
Dec 18, 2045
XS29462437
GlaxoSmithKline Capital Plc 5.25% 10-APR-2042
Yield to maturity
5.61%
Maturity date
Apr 10, 2042
XS35082093
GlaxoSmithKline Capital Plc 6.375% 09-MAR-2039
Yield to maturity
5.44%
Maturity date
Mar 9, 2039
GX4C
GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043
Yield to maturity
5.18%
Maturity date
Mar 18, 2043
XS217060907
GlaxoSmithKline Capital Plc 1.625% 12-MAY-2035
Yield to maturity
4.99%
Maturity date
May 12, 2035
US377372AE7
GlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038
Yield to maturity
4.92%
Maturity date
May 15, 2038
US377372AQ0
GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035
Yield to maturity
4.61%
Maturity date
Apr 15, 2035
XS14051686
GlaxoSmithKline Capital Plc 5.25% 19-DEC-2033
Yield to maturity
4.55%
Maturity date
Dec 19, 2033
US377372AB3
GlaxoSmithKline Capital, Inc. 5.375% 15-APR-2034
Yield to maturity
4.46%
Maturity date
Apr 15, 2034
XS86658852
GlaxoSmithKline Capital Plc 3.375% 20-DEC-2027
Yield to maturity
4.11%
Maturity date
Dec 20, 2027
US377372AP2
GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030
Yield to maturity
4.06%
Maturity date
Apr 15, 2030

See all GSKC bonds 

Curated watchlists where GSKC is featured.